TBG Diagnostics Limited announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was AUD 1.558 million compared to AUD 1.285 million a year ago. Net income was AUD 10.613 million compared to net loss of AUD 2.212 million a year ago. Basic earnings per share was AUD 0.0488 compared to basic loss per share of AUD 0.0102 a year ago. Basic loss per share from continuing operations was AUD 0.0063 compared to AUD 0.007 a year ago.